← Leaderboards
Catherine A Diamond
University Of California Irvine
$867,803
Attributed
$867,803
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $163.9K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$867,803 · 7
By mechanism
K07$634,799 · 1
M01$233,004 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of California Irvine
Same institution · by research overlap
- Ruslan Aphasizhev$17,680,543
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchResourcesFundingResearch PersonnelGrantUnited States National Institutes Of HealthComputer Retrieval Of Information On Scientific Projects DatabaseInstitutionSourceToxic EffectCancer Registry /ResourceLongitudinal Human StudyHelper T LymphocyteRacial /Ethnic DifferenceHuman SubjectNeoplasm /Cancer TherapyCombination ChemotherapyNonhodgkin'S LymphomaLong Term SurvivorNeoplasm /Cancer EpidemiologyDisease /Disorder Proneness /RiskDrug KineticsPrognosisVirus Load
Grant awards (13)
RISK FACTORS FOR COMMUNITY ACQUIRED SKIN AND SOFT TISSUE MRSA INFECTION AMONG HI$6,193
M01 · FY2009 · RR · contact PI
VIRAL DYNAMICS AND PHARMACOKINETICS OF TDF AND ABC MONOTHERAPY VERSUS THE COMB$4,131
M01 · FY2009 · RR · contact PI
CLINICAL TRIAL: A PHASE IV, RANDOMIZED, OPEN-LABEL STUDY OF THE TOLERABILITY OF$46,918
M01 · FY2008 · RR · contact PI
VIRAL DYNAMICS AND PHARMACOKINETICS OF TDF AND ABC MONOTHERAPY VERSUS THE COMB$37,043
M01 · FY2008 · RR · contact PI
VIRAL DYNAMICS AND PHARMACOKINETICS OF TDF AND ABC MONOTHERAPY VERSUS THE COMB$33,450
M01 · FY2007 · RR · contact PI
Treatment and Outcome of AIDS-related Lymphoma$127,170
K07 · FY2006 · CA · contact PI
HAART$5,212
M01 · FY2006 · RR · contact PI
Treatment and Outcome of AIDS-related Lymphoma$127,170
K07 · FY2005 · CA
HAART$36,764
M01 · FY2005 · RR
Treatment and Outcome of AIDS-related Lymphoma$126,622
K07 · FY2004 · CA
HAART$63,293
M01 · FY2004 · RR
Treatment and Outcome of AIDS-related Lymphoma$126,667
K07 · FY2003 · CA
Treatment and Outcome of AIDS-related Lymphoma$127,170
K07 · FY2002 · CA